Evidence map›Paper›PMID 41832956›Full record

ArticleCell reports2026

Radiation-induced autophagy regulates fibroblast mitochondrial metabolism and crosstalk with triple-negative breast cancer cells.

Kevin C Corn, Shannon E Martello, Vinay K Menon, Lucy S Britto, Kara M Simmons, Youssef K Mohamed, Yoanna I Ivanova, Abtin A Ghelmansaraei, Sara A Weidenbach, Tian Zhu and 4 more

Abstract read
In one paragraph

Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Kevin C CornDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Shannon E MartelloDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Vinay K MenonDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Lucy S BrittoDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Kara M SimmonsDepartment of Biology, Tennessee State University, Nashville, TN 37209, USA.
Youssef K MohamedDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Yoanna I IvanovaDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Abtin A GhelmansaraeiDepartment of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Sara A WeidenbachDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Tian ZhuDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA.
Evan S KrystofiakVanderbilt University Cell Imaging Shared Resource, Nashville, TN 37212, USA; Department of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37212, USA.
Jamey D YoungDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA; Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Vivian GamaDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN 37212, USA; Vanderbilt Center for Stem Cell Biology, Vanderbilt University, Nashville, TN 37212, USA; Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN 37212, USA.
Marjan RafatDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN 37212, USA; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37212, USA; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: marjan.rafat@vanderbilt.edu.

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MARY Kay WASHINGTON · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Integrated Training in Engineering and DiabetesT32DK101003 · NIDDK · VANDERBILT UNIVERSITY · PI Jamey D. Young · 2014 to 2026
$3.9M
The BCL-2 family controls stem cell identity by regulating mitochondrial dynamics and primingR35GM128915 · NIGMS · VANDERBILT UNIVERSITY · PI Vivian Gama · 2018 to 2026
$3.8M
MARC at Vanderbilt UniversityT34GM136451 · NIGMS · VANDERBILT UNIVERSITY · PI FRIEDMAN, KATHERINE LOUISE, MCMAHON, DOUGLAS G · 2020 to 2024
$2.0M
Cancer Pharmacologist and HTS ScientistR50CA211206 · NCI · VANDERBILT UNIVERSITY · PI Joshua A. Bauer · 2016 to 2026
$1.8M
Integrated ImageXpress Micro Confocal High Content Screening SystemS10OD028719 · OD · VANDERBILT UNIVERSITY · PI BAUER, JOSHUA A. · 2021 to 2021
$799k
Deconstructing the Tumor Microenvironment and its Role in MetastasisR00CA201304 · NCI · VANDERBILT UNIVERSITY · PI RAFAT, MARJAN · 2018 to 2020
$728k
U-RISE at Tennessee State UniversityT34GM145334 · NIGMS · TENNESSEE STATE UNIVERSITY · PI WHALEN, MARGARET M · 2022 to 2024
$625k
NCI NIH HHS F31 CA298725NCI NIH HHS P30 CA068485NCI NIH HHS R00 CA201304NCI NIH HHS R50 CA211206NEI NIH HHS P30 EY008126NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS T32 DK101003NIDDK NIH HHS U24 DK059637NIGMS NIH HHS R35 GM128915NIGMS NIH HHS T34 GM136451NIGMS NIH HHS T34 GM145334NIH HHS S10 OD028719NIH HHS S10 OD034315NIH HHS S10 OD036367
6 · The paper itself

Abstract

Patients with triple-negative breast cancer (TNBC) experience high recurrence rates despite current interventions, which include radiation therapy (RT). Tumor cells thought to be involved in recurrence may survive in part due to their interactions with irradiated fibroblasts following treatment. How fibroblasts metabolically respond to RT and influence the behavior of TNBC cells is poorly understood. In this study, we demonstrate that irradiated fibroblasts undergo dynamic mitochondrial changes that are regulated by autophagy, resulting in a metabolic profile characterized by high levels of mitochondrial respiration and fatty acid oxidation. These metabolic adaptations lead to a secretory profile that induces an aggressive phenotype in TNBC cells that is mitigated when fibroblast autophagy is blocked. Our work reveals a burgeoning link between post-RT metabolic adaptations in fibroblasts and crosstalk with TNBC cells that promotes a microenvironment conducive to recurrence.

Indexed as

AutophagyFibroblastsMitochondriaTriple Negative Breast NeoplasmsCell Line, TumorFatty AcidsFemaleHumansMetabolic ReprogrammingFatty AcidsautophagyCP: cancerCP: metabolismfatty acid oxidationfibroblastslipid metabolismmitochondrial elongationmitochondrial fusionmitochondrial respirationradiation therapyrecurrencetriple-negative breast cancer

Identifiers

PMID41832956
PMCPMC13094391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.